// App-Quantinova.ai

A-085 : Efficacy and Safety of Pre-Emptive Plasma Exchange and Rituximab in Prevention of Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation in High-Risk Patients

Researchers

Presenter

  • D. Christiadi

Principal Investigators

  • R. Charif

  • A. Kousios

  • M. Loucaidou

Medical Centers

  • Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Urology

Disease

  • Focal segmental glomerulosclerosis

  • Fetal hydronephrosis

  • Albuminuria

  • Hepatitis B

Biomarkers

  • Alpha-Actinin 4

Drug/Treatment

  • Alemtuzumab

  • Tacrolimus

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved